Hospira is a global specialty pharmaceutical and medication delivery company, backed by proven leadership and more than 70 years' experience producing high-quality products. Hospira's breadth of offerings help customers address the safety, productivity and cost of patient care. Used by hospitals worldwide, Hospira products are also prevalent in outpatient clinics and other alternate healthcare sites.
Learn about the Hospira products available in Australia. (Not all Hospira products are available in all countries.) For more information about Hospira's global business, visit Hospira's corporate Web site.
Hospira is the global market leader for generic injectable pharmaceuticals, with one of the broadest generic injectable product portfolios in the world. Our Specialty Injectable Pharmaceuticals offering includes approximately 200 generic injectable drugs in multiple dosages and formulations. In addition, many of our products are available in popular differentiated delivery formats, several of which are proprietary, such as our ADD-Vantage® medication mixing system and our Carpuject® and iSecure™ prefilled syringes. Therapeutic segments include cardiovascular, anesthesia, anti-infectives, oncology, analgesics, emergency and other areas.
Specialty injectables continue to be a key growth opportunity for Hospira. Our robust global product pipeline contains many injectable drugs coming off patent over the next five to seven years, and includes several oncology drugs and biogenerics. Precedex® (dexmedetomidine HCI) injection, Hospira's proprietary sedation agent, represents another growth opportunity.
In 2008, Hospira broadened its global portfolio with the launch of its first biogeneric, Retacrit® (epoetin zeta), in several European countries. Biogeneric products are large complex molecules derived from cells that are demonstrated to be similar to an approved product.
I.V. Solutions, primarily a North American business for Hospira, include large intravenous solutions and nutritionals — essential in virtually every aspect of hospital care.
All of Hospira's injectable I.V. solutions include unit-of-use bar-code labels that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV® next-generation non-PVC, non-DEHP I.V. container, an I.V. bag with advanced safety and environmentally friendly features.
Hospira's global contract manufacturing uses our drug delivery, formulation, filling and finishing expertise — and our reputation for quality — to produce injectable products for some of the world's major proprietary pharmaceutical and biotechnology companies.
Medication Management Systems (MMS), the primary focus of Global Devices, plays a critical role in helping customers improve patient safety and enhance quality of care and clinician workflow. Our MMS portfolio includes a global installed base of more than 400,000 infusion devices, including Symbiq®, our newest and most advanced general infusion device; the Plum A+® line of general infusion pumps; LifeCare PCA®, Hospira's pain management system; the GemStar® line of ambulatory infusion pumps; and other specialty devices.
Integral to Hospira's MMS offering is Hospira MedNet®, our drug-dose safety software that helps reduce medication errors by working to improve the intravenous medication administration process. In addition to tracking drug delivery data, Hospira MedNet provides a useful tool for reporting and compliance purposes.
Hospira's integrated MMS portfolio offers wireless, networking and several cross-platform interfacing capabilities to increase hospital utility, cost-effectiveness and interoperability with other hospital information technology systems. In addition, Hospira's expanding Client Services organization supports customers in maximizing the benefit of our systems.
Clinical decision support tools offered by Hospira include VeriScan® Rx, a hand-held device that supports bar code and radio frequency identification (RFID) medication administration at the point of care and EndoTool® glucose management system, a clinical decision support software system that helps establish and maintain patient glycemic control in acute, critical care and operating room settings.
In addition to MMS, Hospira also offers gravity I.V. administration sets, critical care products and other device products, including LifeShield® products — a line designed to help hospitals take on risk-management issues and move toward better outcomes by controlling contamination and eliminating needlestick injuries and exposure to hazardous materials.